Blog

Health Care Intelligence

 February 17, 2018

“Digiceuticals” Are Gaining Steam

By

“Digiceuticals” Are Gaining Steam For several months now, the FDA has been approving mHealth apps (also known as digital therapeutics or “digiceuticals”) to treat everything from diabetes to substance abuse....

  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
  • Share
 February 12, 2018

In the News: February 8–15

By

This week: Virtual health reimbursement legislation, depression treatment initiation and primary care, and rapid adoption of hospital-based palliative care programs

  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
  • Share
 February 5, 2018

In the News: February 1–8

By

This week: Asthma mortality and care management; Amazon, JP Morgan and Berkshire Hathaway’s health care company; and payment rate increases for Medicare Advantage plans

  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
  • Share
 December 18, 2017

In the News: December 14–21

By

This week: Tax reform bill passes House and Senate, gene therapy for hemophilia, a nationally backed continuum of care for mental health and the repeal of net neutrality

  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
  • Share
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube